HER2/neu Protein News and Research

RSS
HER2/neu is a protein involved in normal cell growth. It is found on some types of cancer cells, including breast and ovarian. Cancer cells removed from the body may be tested for the presence of HER2/neu to help decide the best type of treatment. HER2/neu is a type of receptor tyrosine kinase. Also called c-erbB-2, human EGF receptor 2, and human epidermal growth factor receptor 2.
Scientists create universal assembly method to enhance cancer therapy and diagnostics

Scientists create universal assembly method to enhance cancer therapy and diagnostics

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

Oxis Biotech executes licensing agreement with MCIT for development of antibody-drug conjugates

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

New data highlights molecular profiling in guiding treatment of patients with gynecologic malignancies

Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer patients over IV

Subcutaneous administration of Herceptin preferred by HER2-positive breast cancer patients over IV

Two discriminating biological markers found to predict a favorable response to treatment in triple-negative breast cancer

Two discriminating biological markers found to predict a favorable response to treatment in triple-negative breast cancer

Aggressive breast cancer’s metastasis molecular switch identified

Aggressive breast cancer’s metastasis molecular switch identified

Most triple-negative breast cancer patients have multiple genetic mutations after chemo treatment

Most triple-negative breast cancer patients have multiple genetic mutations after chemo treatment

Study shows increased risk of local recurrence in women with triple negative breast cancer

Study shows increased risk of local recurrence in women with triple negative breast cancer

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Obesity and breast cancer recurrence: an interview with Dr. Joseph Sparano

Anti-HER2 dendritic cell vaccine shows promise against DCIS

Anti-HER2 dendritic cell vaccine shows promise against DCIS

PAM50 test is now available to classify breast cancer subtypes

PAM50 test is now available to classify breast cancer subtypes

HER2/neu protein predicts development of invasive breast cancer in women with ductal carcinoma in situ

HER2/neu protein predicts development of invasive breast cancer in women with ductal carcinoma in situ

New light-based system reveals breast tumor oxygen status

New light-based system reveals breast tumor oxygen status

Laboratory and mouse studies show targeted drug blocks the growth of breast cancer cells that spread to the brain

Laboratory and mouse studies show targeted drug blocks the growth of breast cancer cells that spread to the brain

Biomarkers allow doctors to match therapy to patient

Biomarkers allow doctors to match therapy to patient

Trop-2 new target for anti-tumour therapy in cancer

Trop-2 new target for anti-tumour therapy in cancer

Herceptin does not increase heart failure in patients long-term

Herceptin does not increase heart failure in patients long-term

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Novel method to expand the number of immune system "natural killer" cells from blood cells outside the body

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

Peptide vaccine fights off breast tumors with help of bacteria-mimicking agents

Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging

Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging